Catalyst Wire Dossier Catalyst Wire Dossier

Ebronucimab

Ebronucimab · Akeso
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ebronucimab, covering 2024-10-15 to 2025-06-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects [Phase 1]

See pricing